What are the minimum age and weight requirements for using diclofenac and ketorolac injections for pain management?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 25, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Age and Weight Requirements for Diclofenac and Ketorolac Injections in Children

For ketorolac injections, use in children ≥2 months of age at 0.5 mg/kg IV (maximum 15-30 mg depending on age and weight), while diclofenac IV can be used in children ≥1 year at 0.3 mg/kg (maximum doses vary by formulation). These are the minimum thresholds supported by current evidence, though specific weight minimums are not explicitly defined in guidelines—dosing is primarily weight-based rather than requiring absolute minimum weights.

Ketorolac Injectable - Age and Dosing

Minimum Age

  • ≥2 months of age is supported by recent research evidence 1, 2
  • FDA labeling does not specify pediatric dosing, but clinical practice and research support use from 2 months onward
  • One systematic review from 1997 suggested avoiding use in infants <1 year 3, but more recent data from 2022 demonstrates safety in infants as young as 2 months 1

Dosing by Age/Weight

Single intraoperative dose:

  • 0.5-1 mg/kg IV (maximum 30 mg for single dose) 4

Multiple dosing (postoperative):

  • 0.15-0.2 mg/kg every 6 hours (maximum 10 mg per dose) 4
  • Maximum duration: 48 hours 4, 5
  • Maximum daily dose varies by patient factors (see below)

FDA-approved adult dosing (for reference, though pediatric use is off-label):

  • Adults <65 years: 30 mg IV every 6 hours (max 120 mg/day) 5
  • Adults ≥65 years or <50 kg: 15 mg IV every 6 hours (max 60 mg/day) 5
  • Maximum treatment duration: 5 days 5

Important Caveats for Ketorolac

  • Contraindications: Pre-existing renal dysfunction, coagulation disorders, active bleeding 1
  • Use with caution in:
    • Infants <6 months with single-ventricle palliation
    • Concomitant aspirin use
    • Pre-existing renal impairment 6
  • Recent evidence shows low incidence (1.6%) of major bleeding in infants <6 months when used appropriately 1
  • Transient creatinine elevation may occur in infants <6 months but typically remains within normal limits 6

Diclofenac Injectable - Age and Dosing

Minimum Age

  • ≥1 year of age based on pharmacokinetic studies 7
  • No specific weight minimum is defined; dosing is weight-based

Dosing

Intravenous administration:

  • 0.3 mg/kg for children aged 1-12 years 7
  • This dose yields equivalent AUC to 50 mg adult dose

Alternative formulations (for context):

  • Oral: 1 mg/kg 7
  • Rectal: 0.5 mg/kg 4, 7

Important Considerations for Diclofenac

  • Bioavailability varies significantly by route: IV (100%), rectal (63%), oral suspension (36%) 7
  • Higher volume of distribution in children requires weight-based dosing adjustments 7
  • Similar elimination half-life to adults despite pharmacokinetic differences 7

Clinical Decision Algorithm

For acute postoperative pain in children:

  1. Age 2 months to <1 year:

    • Ketorolac 0.5 mg/kg IV single intraoperative dose, OR
    • Ketorolac 0.15-0.2 mg/kg IV every 6 hours (max 48 hours)
    • Screen for contraindications (renal dysfunction, coagulopathy, cardiac surgery with single ventricle)
  2. Age ≥1 year to 12 years:

    • Either ketorolac (as above) or diclofenac 0.3 mg/kg IV
    • Consider diclofenac if longer duration needed (ketorolac limited to 48 hours)
    • Both are effective; ketorolac may have faster onset 8
  3. Age >12 years:

    • Transition toward adult dosing considerations
    • Weight-based dosing still applies if <50 kg

Safety Profile Comparison

Both medications share similar NSAID-related risks but with important distinctions:

Ketorolac:

  • More data on bleeding risk in pediatric cardiac surgery 6
  • Renal effects more studied in young infants 1
  • Limited to 48 hours in pediatric guidelines 4

Diclofenac:

  • Less pediatric-specific safety data for injectable form
  • Adult studies show comparable efficacy to ketorolac with potentially better opioid-sparing effect 8
  • May have lower GI toxicity profile in some studies

Common Pitfalls to Avoid

  1. Do not exceed maximum duration: Ketorolac should not be used beyond 48 hours in children per current guidelines 4
  2. Do not use in high-risk populations without careful consideration: Avoid in infants with pre-existing renal dysfunction or coagulopathy 1
  3. Do not assume adult dosing applies: Children have different pharmacokinetics requiring weight-based dosing 2, 7
  4. Do not forget multimodal analgesia: Both agents work best as part of opioid-sparing regimens with acetaminophen 6, 4

The evidence strongly supports ketorolac use from 2 months of age and diclofenac from 1 year of age, with weight-based dosing being the primary determinant rather than absolute weight cutoffs. The most recent high-quality evidence demonstrates safety of ketorolac even in very young infants when used appropriately 1.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.